The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

Phase 4 Completed 40 enrolled Oslo University Hospital Pharma Nord · collab

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether supplements of Q10 and Selen are effective in reducing muscular adverse events (AE) in statin therapy.

Timeline

Start: 2005-05
Primary completion: 2007-12
Completion: 2007-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Q10	Unknown	—	—
Subject	Selen	Unknown	—	—

The Effect of Q10 and Selen Supplement on Muscular Adverse Events in Statin Therapy

Summary

Timeline

Drugs

Indications